The decision of whether or not to place a patient with AF on anticoagulation therapy should be based on their individual estimated risk for thromboembolism using the CHA2DS2-VASc score for stroke-risk assessment, which includes DM as a risk factor.
Although consideration of patient adherence is important in treatment decisions, not all patients with AF require anticoagulation. In a recent study of patients with DM and AF, the duration of diabetes was more important than glycemic control in predicting stroke risk. Although electrical cardioversion is highly effective in the acute care setting, patients often revert to AF within 1 year. Chemical cardioversion has not been well-studied in patients with DM.
Learn more about the atrial fibrillation CHA2DS2-VASc score calculator.
Editor's Recommendations
Medscape © 2020 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Sandeep K. Goyal. Fast Five Quiz: Atrial Fibrillation and Diabetes - Medscape - Apr 02, 2020.
Comments